PPLPHARMA — earnings call

The transcript as filed. Every paragraph is addressable: its link names the page and the position it sits at in the call.

Questions and answers

Piramal Pharma Limited

CIN

U24297MH2020PLC338592

Registered Office

Gr.

Flr.

Piramal Ananta, Agastya Corporate Park, Opp Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070 India T +91 22 3802 3000 / 4000 piramal.com

About Piramal Pharma Ltd: · Research Analyst

Piramal Pharma Limited (PPL, NSE: PPLPHARMA | BSE: 543635), offers a portfolio of differentiated products and services through its 17 global facilities which include end-to-end development and manufacturing capabilities and a global distribution network in over 100 countries.

PPL includes Piramal Pharma Solutions (PPS), an integrated Contract Development and Manufacturing Organization; Piramal Critical Care (PCC), a Complex Hospital Generics business; and the India Consumer Healthcare business, selling over-the-counter products.

In addition, PPL has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market and a minority investment in Yapan Bio.

In October 2020, PPL received 20% strategic growth investment from the Carlyle Group.

Conference call on · Research Analyst

https://www.piramal.com/pharma/, Facebook, Twitter, LinkedIn Event

Location & Time · Research Analyst

Telephone Number

Conference call on · Research Analyst

25th May, 2023 India – 5:00 PM IST +91 22 6280 1461 / +91 22 7115 8320 (Primary

Number) · Research Analyst

1 800 120 1221 (Toll free number)

USA – 7:30 AM · Research Analyst

(Eastern Time – New York)

UK – 12:30 PM · Research Analyst

(London Time)

Singapore – 7:30 PM · Research Analyst

(Singapore Time)

Toll free number · Research Analyst

Hong Kong – 7:30 PM (Hong Kong Time)

Express Join with · Research Analyst

Diamond Pass™ Please use this link for prior registration to reduce wait time at the time of joining the call –

https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=459517 · Research Analyst

0&linkSecurityString=17ebb5d7ec

For Media Queries: · Research Analyst

Rajiv Banerjee Group Head - Corporate Communications [identifier removed]

Gagan Borana General Manager - Investor Relations & Sustainability [identifier removed]